Basel Financial Statements From 2010 to 2026

BMGL Stock   0.57  0.08  16.33%   
Basel Medical's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Basel Medical's valuation are provided below:
Gross Profit
3.2 M
Profit Margin
(1.00)
Market Capitalization
10.7 M
Enterprise Value Revenue
1.0837
Revenue
12.1 M
There are over one hundred nineteen available fundamental signals for Basel Medical Group, which can be analyzed over time and compared to other ratios. We recommend to validate Basel Medical's prevailing fundamental drivers against the all of the trends between 2010 and 2026.

Basel Medical Total Revenue

11.48 Million

Check Basel Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Basel Medical's main balance sheet or income statement drivers, such as Interest Income of 125.1 K, Depreciation And Amortization of 781.8 K or Interest Expense of 187.9 K, as well as many indicators such as Price To Sales Ratio of 8.98, Dividend Yield of 0.0 or PTB Ratio of 24.43. Basel financial statements analysis is a perfect complement when working with Basel Medical Valuation or Volatility modules.
  
Build AI portfolio with Basel Stock
Check out the analysis of Basel Medical Correlation against competitors.

Basel Medical Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets18 M19.4 M16.9 M
Slightly volatile
Short and Long Term Debt TotalM3.1 M8.5 M
Slightly volatile
Other Current Liabilities7.5 M7.1 M2.7 M
Slightly volatile
Total Current Liabilities8.7 M12.3 M7.7 M
Slightly volatile
Total Stockholder Equity5.9 M5.6 M4.3 M
Slightly volatile
Property Plant And Equipment Net4.2 MM1.6 M
Slightly volatile
Net Debt376.5 K396.4 K6.6 M
Slightly volatile
Accounts Payable1.5 M2.4 M1.3 M
Slightly volatile
Cash2.1 M3.4 M1.8 M
Slightly volatile
Non Current Assets Total4.5 M4.3 M1.6 M
Slightly volatile
Long Term Debt2.7 M1.4 M4.4 M
Slightly volatile
Cash And Short Term Investments2.1 M3.4 M1.8 M
Slightly volatile
Net Receivables2.1 M2.2 M11.7 M
Slightly volatile
Common Stock Shares Outstanding20.6 M21.6 M19 M
Slightly volatile
Liabilities And Stockholders Equity18 M19.4 M16.9 M
Slightly volatile
Non Current Liabilities Total1.1 M1.2 M4.7 M
Slightly volatile
Capital Lease Obligations4.1 M3.9 M1.6 M
Slightly volatile
Inventory454.4 K432.7 K133.4 K
Slightly volatile
Other Current Assets8.8 M8.4 M1.6 M
Slightly volatile
Total Liabilities8.8 M10.8 M12.2 M
Slightly volatile
Net Invested Capital8.3 M4.4 M11.4 M
Slightly volatile
Property Plant And Equipment Gross5.9 M11.5 M4.8 M
Slightly volatile
Short and Long Term Debt52.5 K55.2 K2.9 M
Slightly volatile
Total Current Assets11.9 M11.8 M15 M
Slightly volatile
Capital Stock41.3 M39.3 M8.2 M
Slightly volatile
Net Working Capital2.1 M2.2 M7.4 M
Slightly volatile
Short Term Debt2.6 M1.9 M3.7 M
Slightly volatile
Common Stock41.3 M39.3 M8.2 M
Slightly volatile

Basel Medical Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization781.8 K1.4 M665.8 K
Slightly volatile
Interest Expense187.9 K183.6 K284.7 K
Slightly volatile
Selling General Administrative4.8 M7.5 M4.4 M
Slightly volatile
Total Revenue11.5 M13 M10.8 M
Slightly volatile
Gross Profit8.9 M10.1 M8.5 M
Pretty Stable
Other Operating Expenses10.2 M15.5 MM
Slightly volatile
Cost Of Revenue2.6 M2.9 M2.3 M
Slightly volatile
Total Operating Expenses7.7 M12.6 M6.7 M
Slightly volatile
Reconciled Depreciation781.8 K1.4 M665.8 K
Slightly volatile
Minority Interest401451492
Slightly volatile

Basel Medical Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Begin Period Cash Flow3.3 M1.8 M8.9 M
Slightly volatile
Depreciation781.8 K1.4 M665.8 K
Slightly volatile
Capital Expenditures31.5 K49.3 K71.3 K
Slightly volatile
End Period Cash Flow2.1 M3.4 M1.8 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio8.9810.110.7853
Slightly volatile
PTB Ratio24.4317.1627.4403
Slightly volatile
Days Sales Outstanding87.8892.51407
Slightly volatile
Book Value Per Share0.240.360.2395
Slightly volatile
Free Cash Flow Yield0.02520.02550.0234
Pretty Stable
Operating Cash Flow Per Share0.150.13380.1467
Slightly volatile
Average PayablesM1.3 M1.3 M
Pretty Stable
Capex To Depreciation0.06220.05330.1195
Slightly volatile
PB Ratio24.4317.1627.4403
Slightly volatile
EV To Sales0.04250.04479.6289
Slightly volatile
Free Cash Flow Per Share0.150.13340.1433
Pretty Stable
Inventory Turnover7.337.7226.596
Slightly volatile
Net Income Per Share0.080.09950.1036
Slightly volatile
Days Of Inventory On Hand51.3848.9318.9125
Slightly volatile
Payables Turnover2.071.391.9531
Slightly volatile
Sales General And Administrative To Revenue0.330.520.3929
Slightly volatile
Average Inventory103.9 K201.7 K98.9 K
Slightly volatile
Capex To Revenue0.0040.00560.0068
Slightly volatile
Cash Per Share0.06730.09370.0844
Pretty Stable
POCF Ratio34.5840.4741.4876
Very volatile
PFCF Ratio35.0140.642.5002
Slightly volatile
Days Payables Outstanding169273193
Slightly volatile
Income Quality0.380.41.0254
Slightly volatile
PE Ratio64.5562.658.8717
Pretty Stable
Earnings Yield0.01370.01650.0169
Slightly volatile
Current Ratio2.191.412.0886
Slightly volatile
Tangible Book Value Per Share0.240.360.2395
Slightly volatile
Receivables Turnover4.294.081.3915
Slightly volatile
Shareholders Equity Per Share0.240.360.2395
Slightly volatile
Debt To Equity1.460.812.2197
Slightly volatile
Capex Per Share5.0E-45.0E-40.0035
Slightly volatile
Average Receivables11.2 M8.6 M12.2 M
Slightly volatile
Revenue Per Share0.590.620.5659
Very volatile
Interest Debt Per Share0.440.270.4875
Slightly volatile
Debt To Assets0.420.230.5186
Slightly volatile
Graham Number0.660.90.7396
Slightly volatile
Price Earnings Ratio64.5562.658.8717
Pretty Stable
Operating Cycle147155427
Slightly volatile
Price Book Value Ratio24.4317.1627.4403
Slightly volatile
Days Of Payables Outstanding169273193
Slightly volatile
Price To Operating Cash Flows Ratio34.5840.4741.4876
Very volatile
Price To Free Cash Flows Ratio35.0140.642.5002
Slightly volatile
Ebt Per Ebit5.415.161.7666
Slightly volatile
Effective Tax Rate0.03650.03840.1449
Slightly volatile
Company Equity Multiplier3.563.994.1493
Slightly volatile
Long Term Debt To Capitalization0.190.20.4816
Slightly volatile
Total Debt To Capitalization0.570.470.6573
Slightly volatile
Debt Equity Ratio1.460.812.2197
Slightly volatile
Quick Ratio2.171.372.0747
Slightly volatile
Net Income Per E B T0.70.870.8342
Very volatile
Cash Ratio0.190.250.2228
Slightly volatile
Days Of Inventory Outstanding51.3848.9318.9125
Slightly volatile
Days Of Sales Outstanding87.8892.51407
Slightly volatile
Free Cash Flow Operating Cash Flow Ratio0.790.910.9604
Slightly volatile
Price To Book Ratio24.4317.1627.4403
Slightly volatile
Fixed Asset Turnover2.82.9518.1056
Pretty Stable
Price Cash Flow Ratio34.5840.4741.4876
Very volatile
Debt Ratio0.420.230.5186
Slightly volatile
Price Sales Ratio8.9810.110.7853
Slightly volatile
Asset Turnover0.510.60.6247
Slightly volatile
Gross Profit Margin0.860.890.8005
Slightly volatile
Price Fair Value24.4317.1627.4403
Slightly volatile

Basel Medical Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap125.5 M129.5 M116.5 M
Slightly volatile
Enterprise Value133.5 M136.4 M124.5 M
Pretty Stable

Basel Fundamental Market Drivers

About Basel Medical Financial Statements

Basel Medical investors utilize fundamental indicators, such as revenue or net income, to predict how Basel Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Total Revenue13 M11.5 M
Cost Of Revenue2.9 M2.6 M
Sales General And Administrative To Revenue 0.52  0.33 
Revenue Per Share 0.62  0.59 
Ebit Per Revenue(0.22)(0.21)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether Basel Medical Group is a strong investment it is important to analyze Basel Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Basel Medical's future performance. For an informed investment choice regarding Basel Stock, refer to the following important reports:
Check out the analysis of Basel Medical Correlation against competitors.
You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Basel Medical. If investors know Basel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Basel Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.50)
Revenue Per Share
0.644
Quarterly Revenue Growth
0.322
Return On Assets
(0.05)
Return On Equity
(1.95)
The market value of Basel Medical Group is measured differently than its book value, which is the value of Basel that is recorded on the company's balance sheet. Investors also form their own opinion of Basel Medical's value that differs from its market value or its book value, called intrinsic value, which is Basel Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Basel Medical's market value can be influenced by many factors that don't directly affect Basel Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Basel Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Basel Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Basel Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.